Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AT&T Inc. (T) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

AT&T Inc.Trade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

AT&T Inc. vs Health Care Select Sector SPDR Fund — how do they compare? AT&T Inc. trades at $22.23 (market cap $152.52B), while Health Care Select Sector SPDR Fund trades at $160.16. The key difference: AT&T Inc. pays a 5.06% dividend while Health Care Select Sector SPDR Fund pays none, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, AT&T Inc. nearer its low. Which is the better fit depends on your goals.

TXLV
Market Cap
$152.52B
Sector
Media
52-Week High
$29.62$164.48
52-Week Low
$20.49$129.01
Enterprise Value
$297.87B
Dividend Yield
5.06%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AT&T Inc.

AT&T (T) trades at $22.26, up 2.13% with a bullish technical signal despite mixed moving averages. The stock shows strong fundamentals with a low P/E of 7.39, robust profitability margins (net margin 16.94%), and consistent earnings beats in recent quarters. Recent cash flow improvement to $15.12B in 2025 and declining debt-to-asset ratio to 32.59% in 2024 signal financial health. The company faces competitive pressures in telecom but benefits from fiber expansion and stable wireless pricing.

Outlook remains positive with analyst consensus target of $25.61 offering 15% upside. Key opportunities include dividend yield support and fiber growth, while risks involve intense telecom competition and potential earnings volatility. Wall Street sentiment is cautiously optimistic with 41% buy ratings, though technical indicators show some overbought conditions near-term.

Health Care Select Sector SPDR Fund

XLV trades at $159.25, down 1.14% with neutral technical signals overall. The healthcare ETF shows mixed momentum with bullish moving averages but neutral oscillators. Recent news highlights XLV's defensive characteristics amid market volatility, with State Street upgrading healthcare to positive for Q3 2026. The fund's diversified approach offers stability compared to more volatile biotech-focused alternatives.

XLV presents a defensive opportunity with lower costs and steady performance, though upside may be limited in the current cycle. Key risks include patent cliff concerns and sector rotation away from defensive plays if market sentiment improves. The ETF's broad healthcare exposure provides cushion against individual stock volatility while benefiting from pipeline innovations.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AT&T Inc.

AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.

Read more on T

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV